All sponsors

Inmunotek S.L.

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS7
PHASE 3 / 2-37
RECRUITING6
READOUTS ≤12 MONTHS1
Open Inmunotek S.L. on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
10,000 MG01 + 10,000 T517
NCT04891237
P3RecruitingRhinitis, Allergic; Rhinoconjunctivitis1802026-01 (+37 mo)
MM09-SLIM
NCT05641272
P2/3Not yet recruitingAllergic Rhinitis; Allergic Asthma902026-06-01
10,000 MG01 +10,000 T521
NCT04898283
P3RecruitingRhinitis, Allergic; Rhinoconjunctivitis1802026-10 (+46 mo)
MM09-SIT-023
NCT04435990
P3RecruitingRhinitis, Allergic; Rhinoconjunctivitis1502026-12 (+71 mo)
Oraltek-58
NCT07348302
P3RecruitingRhinitis; Rhinoconjunctivitis7362029-04-27
MM09-SIT-063
NCT07904052
P3RecruitingAllergic Rhinitis; Allergic Rhinoconjunctivitis2502029-07
EP-088_MM09
NCT07904195
P3RecruitingAllergic Rhinitis; Allergic Rhinoconjunctivitis2502029-07